Health ❯ Healthcare

Weight Loss

Medications Weight Loss Drugs Side Effects Pharmaceuticals Injections Bariatric Surgery Personal Experiences Obesity Treatment Obesity GLP-1 Drugs

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

Short-follow-up modeling indicates rapid regain after discontinuation, prompting trials of tapering or maintenance dosing.

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Boots Pilots First High‑Street Prescribing Service for Wegovy and Mounjaro

Serena Williams’ Super Bowl Ro Ad Promotes GLP-1 Weight Loss, Draws Backlash

Super Bowl LX Ad Buys Hit Record as $8 Million Spots Sell Out and AI, Health Take Center Stage

Jub Jub Posts Pre-Op Video as He Prepares for Abdominal Cosmetic Surgery

Serena Williams Leads Ro’s Super Bowl GLP-1 Campaign, Citing Major Health Gains

Survey Finds 39% of UK Private Weight-Loss Jab Users in Debt

Alveus Therapeutics Launches With $159.8 Million Series A to Advance Next‑Generation Obesity Drugs

Amy Tapper Says She’ll Stay on Mounjaro for Life After 7.5-Stone Weight Loss

Mounjaro Price Rise Drives Up Out-of-Pocket Costs for UK Users

Study Finds One in Five Ozempic, Wegovy, Mounjaro Users Report Taste Changes

Oprah Shares Slimmer Book Club Photo, Disables Comments

UK Mounjaro Price Surge Fuels Switching, Stockpiling and Illicit Supply Concerns

Wegovy Sales Soar as UK Mounjaro Price Jumps 170%

GLP-1 Drugs Linked to Lower Overall Cancer Risk in JAMA Oncology Analysis

Superdrug Halts Mounjaro Sales as Panic Buying Triggers Shortages Before Price Hike

Mounjaro Price Hike Triggers Stockpiling and Shift to Ozempic and Wegovy

Sheyla Tadeo’s Weight-Loss Journey and Skin Donation Resurface Online

Morrisons Launches £129-a-Month Subscription for Weekly Weight-Loss Injections